Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Jin L"" wg kryterium: Autor


Tytuł:
The effect on income of providing near vision correction to workers in Bangladesh: The THRIVE (Tradespeople and Hand-workers Rural Initiative for a Vision-enhanced Economy) randomized controlled trial.
Autorzy:
Sehrin F; BRAC (Formerly: Bangladesh Rural Advancement Committee), Dhaka, Bangladesh.
Jin L; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
Naher K; BRAC (Formerly: Bangladesh Rural Advancement Committee), Dhaka, Bangladesh.
Das NC; BRAC (Formerly: Bangladesh Rural Advancement Committee), Dhaka, Bangladesh.
Chan VF; University of KwaZulu Natal, Durban, South Africa.; Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Li DF; Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Bergson S; VisionSpring, New York, New York, United States of America.
Gudwin E; VisionSpring, New York, New York, United States of America.
Clarke M; Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Stephan T; Orbis International, New York, New York, United States of America.
Congdon N; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.; Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.; Orbis International, New York, New York, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 03; Vol. 19 (4), pp. e0296115. Date of Electronic Publication: 2024 Apr 03 (Print Publication: 2024).
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Presbyopia*
Myopia*
Humans ; Male ; Middle Aged ; Female ; Quality of Life ; Bangladesh ; Vision, Ocular
Czasopismo naukowe
Tytuł:
[Exploration of the method and efficacy of treatments for intractable pelvic pain caused by rectal or bladder fistula].
Autorzy:
Zhang YM; Department of Gynecology, the First People's Hospital of Yinchuan, the Second Clinical Medical College of Ningxia Medical University, Yinchuan 750001, China.
Wang GC; Department of Abdominopelvic Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Liu YJ; Department of General Surgery, Henan Provincial Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Wang YC; Department of General Surgery, Henan Provincial Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Zhang GQ; Department of General Surgery, Henan Provincial Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Zhang Y; Department of General Surgery, Henan Provincial Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Gao CQ; Department of General Surgery, Henan Provincial Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Wang C; Department of General Surgery, Henan Provincial Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Zhang Z; Department of General Surgery, Henan Provincial Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Yang J; Department of Gynecology, the First People's Hospital of Yinchuan, the Second Clinical Medical College of Ningxia Medical University, Yinchuan 750001, China.
Jin L; Department of Gynecology, the First People's Hospital of Yinchuan, the Second Clinical Medical College of Ningxia Medical University, Yinchuan 750001, China.
Wang YP; Department of Gynecology, the First People's Hospital of Yinchuan, the Second Clinical Medical College of Ningxia Medical University, Yinchuan 750001, China.
Niu ZL; Department of Gynecology, the First People's Hospital of Yinchuan, the Second Clinical Medical College of Ningxia Medical University, Yinchuan 750001, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Mar 23; Vol. 46 (3), pp. 263-268.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/complications
Uterine Cervical Neoplasms*/pathology
Rectal Neoplasms*/complications
Rectal Neoplasms*/surgery
Rectal Neoplasms*/drug therapy
Female ; Humans ; Retrospective Studies ; Quality of Life ; Urinary Bladder/pathology ; Pelvic Pain/drug therapy ; Pelvic Pain/etiology ; Treatment Outcome
Czasopismo naukowe
Tytuł:
TLR3 Agonist Amplifies the Anti-Inflammatory Potency of ADSCs via IL-10-Mediated Macrophage Polarization in Acute Pancreatitis.
Autorzy:
Liu J; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, China.
Yan W; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, China.
Chen S; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, China.
Sun Y; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, China.
Zhang F; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, China.
Yang Y; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, China.
Jin L; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, China.
Pokaż więcej
Źródło:
Stem cells international [Stem Cells Int] 2024 Mar 21; Vol. 2024, pp. 5579228. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Chlojaponilactone B Attenuates THP-1 Macrophage Pyroptosis by Inhibiting the TLR/MyD88/NF-κB Pathway.
Autorzy:
Wen Q; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Zhan B; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Jin L; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Peng Z; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Liu J; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Zhu L; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Yang D; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Xu X; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Zhang L; Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Jinghong 666100, China.
Li G; Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Jinghong 666100, China.
Zhao Z; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Pokaż więcej
Źródło:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2024 Mar 21; Vol. 17 (3). Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Chicoric Acid Ameliorated Beta-Amyloid Pathology and Enhanced Expression of Synaptic-Function-Related Markers via L1CAM in Alzheimer's Disease Models.
Autorzy:
Wang R; National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China.; School of Integrated Chinese and Western Medicine, Dalian Medical University, Dalian 116044, China.
Kang S; National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China.; School of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
Zhao Z; National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China.; School of Integrated Chinese and Western Medicine, Dalian Medical University, Dalian 116044, China.
Jin L; National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China.
Cui X; National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China.
Chen L; National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China.
Schachner M; Keck Center for Collaborative Neuroscience and Department of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Li S; National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China.; Department of Biochemistry, School of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
Guo Y; National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China.; Department of Microecology, School of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
Zhao J; National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 17; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 17.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/drug therapy
Alzheimer Disease*/genetics
Alzheimer Disease*/metabolism
Neural Cell Adhesion Molecule L1*
Neurodegenerative Diseases*
Neuroblastoma*
Caffeic Acids*
Succinates*
Humans ; Mice ; Animals ; Amyloid Precursor Protein Secretases/genetics ; Amyloid Precursor Protein Secretases/metabolism ; Amyloid beta-Protein Precursor/metabolism ; Mice, Transgenic ; Disease Models, Animal ; Aspartic Acid Endopeptidases/metabolism ; Amyloid beta-Peptides/metabolism
Czasopismo naukowe
Tytuł:
Microsurgical Vitrectomy with Pars Plana Incision for the Removal of Posterior Segment Intraocular Foreign Bodies.
Autorzy:
Liu X; Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Ji MM; Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Jin L; Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Zeng AP; Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Pokaż więcej
Źródło:
Journal of ophthalmology [J Ophthalmol] 2024 Mar 09; Vol. 2024, pp. 3270197. Date of Electronic Publication: 2024 Mar 09 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial.
Autorzy:
Fan C; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wang X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zheng X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Sun Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Ye K; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Jiang Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Xu W; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Yang Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Jiang Q; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
He C; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wu X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Nie X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zhang J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Tan B; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wang W; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zhang Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Feng Z; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Yang C; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Lu Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu H; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Chen X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Xu J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu F; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zheng X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wang J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wu S; Xinyang Hospital Affiliated to Zhengzhou University & Xinyang Central Hospital, Xinyang, 464000, China.
Chen G; Xinyang Hospital Affiliated to Zhengzhou University & Xinyang Central Hospital, Xinyang, 464000, China.
Zhang Y; Anyang Cancer Hospital, Anyang, 455000, China.
Jin L; Anyang Cancer Hospital, Anyang, 455000, China.
Ge H; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 07; Vol. 24 (1), pp. 321. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Multicenter Study; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/therapy
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/radiotherapy
Humans ; Consolidation Chemotherapy ; Prospective Studies ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemoradiotherapy ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Auxin and carbohydrate control flower bud development in Anthurium andraeanum during early stage of sexual reproduction.
Autorzy:
Wan X; Zhejiang Institute of Landscape Plants and Flowers, Zhejiang Academy of Agricultural Sciences, Hangzhou, 311251, Zhejiang, China. .
Zou LH; State Key Laboratory of Subtropical Silviculture, Bamboo Industry Institute, Zhejiang A&F University, Hangzhou, 311300, Zhejiang, China.
Pan X; Zhejiang Institute of Landscape Plants and Flowers, Zhejiang Academy of Agricultural Sciences, Hangzhou, 311251, Zhejiang, China.
Ge Y; Zhejiang Institute of Landscape Plants and Flowers, Zhejiang Academy of Agricultural Sciences, Hangzhou, 311251, Zhejiang, China.
Jin L; Zhejiang Institute of Landscape Plants and Flowers, Zhejiang Academy of Agricultural Sciences, Hangzhou, 311251, Zhejiang, China.
Cao Q; Zhejiang Institute of Landscape Plants and Flowers, Zhejiang Academy of Agricultural Sciences, Hangzhou, 311251, Zhejiang, China.
Shi J; Zhejiang Institute of Landscape Plants and Flowers, Zhejiang Academy of Agricultural Sciences, Hangzhou, 311251, Zhejiang, China.
Tian D; Zhejiang Institute of Landscape Plants and Flowers, Zhejiang Academy of Agricultural Sciences, Hangzhou, 311251, Zhejiang, China. .
Pokaż więcej
Źródło:
BMC plant biology [BMC Plant Biol] 2024 Mar 02; Vol. 24 (1), pp. 159. Date of Electronic Publication: 2024 Mar 02.
Typ publikacji:
Journal Article
MeSH Terms:
Reproduction*
Araceae*/genetics
Female ; Pregnancy ; Humans ; Sucrose ; Flowers/genetics ; Indoleacetic Acids
Czasopismo naukowe
Tytuł:
Retraction Note: Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells.
Autorzy:
Wang S; Department of Gastroenterology, The Affiliated Hospital of Qingdao University, 266000, Qingdao, China.
Zhang X; Department of Gastroenterology, The Affiliated Hospital of Qingdao University, 266000, Qingdao, China.
Wang G; Department of Geriatrics, The Affiliated Hospital of Qingdao University, No.59 Haier Road, Laoshan District, 266000, Qingdao, Shandong, China.
Cao B; Department of Gastroenterology, The Affiliated Hospital of Qingdao University, 266000, Qingdao, China.
Yang H; Emergency Department, The Affiliated Hospital of Qingdao University, 266000, Qingdao, China.
Jin L; Department of Gastroenterology, The Affiliated Hospital of Qingdao University, 266000, Qingdao, China.
Cui M; Department of Gastroenterology, The Affiliated Hospital of Qingdao University, 266000, Qingdao, China.
Mao Y; Department of Geriatrics, The Affiliated Hospital of Qingdao University, No.59 Haier Road, Laoshan District, 266000, Qingdao, Shandong, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 01; Vol. 24 (1), pp. 277. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Retraction of Publication
Tytuł:
Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile.
Autorzy:
Wang T; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China.; GeneScience Pharmaceuticals Co., Ltd, Changchun, 130012, Jilin, People's Republic of China.
Wang SQ; GeneScience Pharmaceuticals Co., Ltd, Changchun, 130012, Jilin, People's Republic of China.
Du YX; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China.
Sun DD; GeneScience Pharmaceuticals Co., Ltd, Changchun, 130012, Jilin, People's Republic of China.
Liu C; GeneScience Pharmaceuticals Co., Ltd, Changchun, 130012, Jilin, People's Republic of China.
Liu S; GeneScience Pharmaceuticals Co., Ltd, Changchun, 130012, Jilin, People's Republic of China.
Sun YY; GeneScience Pharmaceuticals Co., Ltd, Changchun, 130012, Jilin, People's Republic of China.
Wang HL; GeneScience Pharmaceuticals Co., Ltd, Changchun, 130012, Jilin, People's Republic of China.
Zhang CS; GeneScience Pharmaceuticals Co., Ltd, Changchun, 130012, Jilin, People's Republic of China.
Liu HL; GeneScience Pharmaceuticals Co., Ltd, Changchun, 130012, Jilin, People's Republic of China.
Jin L; GeneScience Pharmaceuticals Co., Ltd, Changchun, 130012, Jilin, People's Republic of China. .
Chen XP; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Mar 01; Vol. 22 (1), pp. 220. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
CD47 Antigen*
Neoplasms*/pathology
Animals ; Humans ; Phagocytosis ; Macrophages/metabolism ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Immunotherapy/methods ; Disease Models, Animal ; Antigens, Differentiation/metabolism ; Antigens, Differentiation/pharmacology ; Antigens, Differentiation/therapeutic use
Czasopismo naukowe
Tytuł:
FGF18 alleviates sepsis-induced acute lung injury by inhibiting the NF-κB pathway.
Autorzy:
Hu Z; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Dai J; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Xu T; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Chen H; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Shen G; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Zhou J; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Ma H; School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.
Wang Y; School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China. .
Jin L; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China. jin_.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2024 Feb 28; Vol. 25 (1), pp. 108. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Acute Lung Injury*/metabolism
Sepsis*/metabolism
Fibroblast Growth Factors*
Mice ; Humans ; Animals ; NF-kappa B/metabolism ; Lipopolysaccharides/toxicity ; Mice, Inbred C57BL ; Lung/metabolism ; Human Umbilical Vein Endothelial Cells/metabolism ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł:
Incidence and influence factors of venous thromboembolism in traumatic rib fracture patient: a multicenter study.
Autorzy:
Zhang D; Department of Cardiothoracic Surgery, Shijiazhuang Third Hospital, Shijiazhuang, 050000, Hebei, China. .
Yang Y; Department of Thoracic Surgery, Shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital, Shanghai, 200233, China. .
Yi Y; Department of Cardiothoracic Surgery, Dongnan Hospital of Xiamen University, School of Medicine, Xiamen University, Zhangzhou, 363000, Fujian, China.
Wang D; Department of Cardiothoracic Surgery, Tianjin Hospital Affiliated to Tianjin University, Tianjin, 300211, China.
Jiang L; The Second Department of Surgery (Thoracic and Breast Department), Foshan Hospital of Traditional Chinese Medicine, Foshan, 528000, Guangdong, China.
Huang H; Department of Thoracic Surgery, Fuzhou Second Hospital, Fuzhou, 350007, Fujian, China.
Jin L; Department of Thoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, 410000, Hunan, China.
Meng H; Department of Thoracic Surgery, The Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, 519100, Guangdong, China.
Xia F; Department of Emergency Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, Guizhou, China.
Guo G; Department of Cardiothoracic Surgery, Second Hospital of Shanxi Medical University, Taiyuan, 030000, Shanxi, China.
Pokaż więcej
Źródło:
Journal of orthopaedic surgery and research [J Orthop Surg Res] 2024 Feb 23; Vol. 19 (1), pp. 152. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Rib Fractures*/complications
Rib Fractures*/epidemiology
Thrombosis*
Humans ; Anticoagulants/therapeutic use ; Incidence ; Retrospective Studies ; Risk Factors ; Ribs
Czasopismo naukowe
Tytuł:
Identification of key potential infection processes and risk factors in the computed tomography examination process by FMEA method under COVID-19.
Autorzy:
Jin L; Radiology department, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China.
Ye M; Radiology department, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China.
Lin W; Radiology department, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China.
Ye Y; Institute of Public Health and Emergency Management, Taizhou University, Taizhou, Zhejiang, China.; Business College, Taizhou University, Taizhou, Zhejiang, China.
Chuang YC; Institute of Public Health and Emergency Management, Taizhou University, Taizhou, Zhejiang, China. .; Business College, Taizhou University, Taizhou, Zhejiang, China. .; Key Laboratory of evidence-based Radiology of Taizhou, Linhai, Zhejiang, China. .
Luo JY; Institute for Hospital Management, Tsing Hua University, Shenzhen, Guangdong, China. .
Tang F; Nursing Department, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 23; Vol. 24 (1), pp. 257. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Cross Infection*/prevention & control
Humans ; Risk Factors ; Tomography, X-Ray Computed ; Tomography
Czasopismo naukowe
Tytuł:
Efficacy of Alveolar Ridge Preservation in Periodontally Compromised Molar Extraction Sites: A Systematic Review and Meta-Analysis.
Autorzy:
Fok MR; Division of Periodontology and Implant Dentistry, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
Pelekos G; Division of Periodontology and Implant Dentistry, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
Jin L; Division of Periodontology and Implant Dentistry, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2024 Feb 20; Vol. 13 (5). Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Comparative Analysis of GF-5 and Sentinel-2A Fusion Methods for Lithological Classification: The Tuanjie Peak, Xinjiang Case Study.
Autorzy:
Chi Y; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi 830011, China.; University of Chinese Academy of Sciences, Beijing 100049, China.; Xinjiang Key Laboratory of Mineral Resources and Digital Geology, Urumqi 830011, China.; Xinjiang Research Center for Mineral Resources, Chinese Academy of Sciences, Urumqi 830011, China.
Zhang N; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi 830011, China.; University of Chinese Academy of Sciences, Beijing 100049, China.; Xinjiang Key Laboratory of Mineral Resources and Digital Geology, Urumqi 830011, China.; Xinjiang Research Center for Mineral Resources, Chinese Academy of Sciences, Urumqi 830011, China.
Jin L; Geological Survey Academy of Xinjiang, Urumqi 830000, China.
Liao S; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi 830011, China.; University of Chinese Academy of Sciences, Beijing 100049, China.; Xinjiang Key Laboratory of Mineral Resources and Digital Geology, Urumqi 830011, China.; Xinjiang Research Center for Mineral Resources, Chinese Academy of Sciences, Urumqi 830011, China.
Zhang H; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi 830011, China.; University of Chinese Academy of Sciences, Beijing 100049, China.; Xinjiang Key Laboratory of Mineral Resources and Digital Geology, Urumqi 830011, China.; Xinjiang Research Center for Mineral Resources, Chinese Academy of Sciences, Urumqi 830011, China.
Chen L; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi 830011, China.; University of Chinese Academy of Sciences, Beijing 100049, China.; Xinjiang Key Laboratory of Mineral Resources and Digital Geology, Urumqi 830011, China.; Xinjiang Research Center for Mineral Resources, Chinese Academy of Sciences, Urumqi 830011, China.
Pokaż więcej
Źródło:
Sensors (Basel, Switzerland) [Sensors (Basel)] 2024 Feb 16; Vol. 24 (4). Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2023 ASH annual meeting.
Autorzy:
Gong X; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
He X; Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.
Wang L; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
Yu T; Department of Hematology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.
Liu W; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
Xu H; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
Jin L; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
Li X; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
Zhang B; Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA. .
Tao Z; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China. .
Qian W; Department of Hematology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China. .
Pokaż więcej
Źródło:
Experimental hematology & oncology [Exp Hematol Oncol] 2024 Feb 16; Vol. 13 (1), pp. 17. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Letter
Opinia redakcyjna
Tytuł:
Teleoperated Grasping Using Data Gloves Based on Fuzzy Logic Controller.
Autorzy:
Lu C; School of Automotive Engineering, Harbin Institute of Technology (Weihai), Weihai 264209, China.
Jin L; School of Automotive Engineering, Harbin Institute of Technology (Weihai), Weihai 264209, China.
Liu Y; China North Vehicle Research Institute, Beijing 100072, China.
Wang J; School of Automotive Engineering, Harbin Institute of Technology (Weihai), Weihai 264209, China.
Li W; School of Automotive Engineering, Harbin Institute of Technology (Weihai), Weihai 264209, China.; Yangtze River Delta HIT Robot Technology Research Institute, Wuhu 241060, China.
Pokaż więcej
Źródło:
Biomimetics (Basel, Switzerland) [Biomimetics (Basel)] 2024 Feb 15; Vol. 9 (2). Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Compliant-Control-Based Assisted Walking with Mobile Manipulator.
Autorzy:
Li W; School of Automotive Engineering, Harbin Institute of Technology-Weihai, Weihai 264201, China.; Yangtze River Delta HIT Robot Technology Research Institute, Wuhu 241060, China.; State Key Laboratory of Robotics and System, Harbin Institute of Technology, Harbin 150001, China.
Li P; School of Automotive Engineering, Harbin Institute of Technology-Weihai, Weihai 264201, China.
Jin L; School of Automotive Engineering, Harbin Institute of Technology-Weihai, Weihai 264201, China.
Xu R; School of Automotive Engineering, Harbin Institute of Technology-Weihai, Weihai 264201, China.
Guo J; School of Automotive Engineering, Harbin Institute of Technology-Weihai, Weihai 264201, China.
Wang J; School of Automotive Engineering, Harbin Institute of Technology-Weihai, Weihai 264201, China.
Pokaż więcej
Źródło:
Biomimetics (Basel, Switzerland) [Biomimetics (Basel)] 2024 Feb 09; Vol. 9 (2). Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
An empirical assessment of whether urban green ecological networks have the capacity to store higher levels of carbon.
Autorzy:
Wan Y; School of Architecture, China Architecture Design & Research Group, Beijing, China.
Wang Y; Department of Landscape Architecture, Huazhong Agricultural University, Wuhan, China.
Gao M; School of Architecture, Harbin Institute of Technology, Harbin, China.; Key Laboratory of Cold Region Urban and Rural Human Settlement Environment Science and Technology, Ministry of Industry and Information Technology, Harbin, China.
Jin L; Interdisciplinary Program in Landscape Architecture, Seoul National University, Seoul, Republic of Korea. .; Integrated Major in Smart City Global Convergence, Seoul National University, Seoul, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 07; Vol. 14 (1), pp. 3132. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies